查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
整形外科植入的全球市场：按产品、按材料、按最终用户、按地区 - 预测至 2029 年
市场调查报告书
商品编码
1608637

整形外科植入的全球市场：按产品、按材料、按最终用户、按地区 - 预测至 2029 年

Orthopaedic Implants Market by Product, Material (Metals Polymers, Ceramics, Hybrid), End user -Global Forecast To 2029
出版日期: | 出版商: MarketsandMarkets | 英文 260 Pages | 订单完成后即时交付

价格

全球整形外科植入市场规模预计将从2024年的209.4亿美元达到2029年的264.7亿美元，2024年至2029年的复合年增长率为4.8%。各种类型的整形外科植入的增加和技术进步（例如在製造过程中使用 3D 列印）正在增加对整形外科植入的需求。此外，可能导致骨折和关节损伤的事故和运动伤害发生率不断上升，也推动了对整形外科植入的需求。

调查范围
调查年份 2022-2029
基准年 2023年
预测期 2024-2029
考虑单位 金额（美元）
按细分市场 按产品、材料、最终用户、地区
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东非洲

整形外科植入市场按类型分为膝部植入、髋部植入、肩部植入、肘部植入、足部和踝部植入、腕部植入和其他植入。 2023年，膝关节植入将拥有最高的市场份额。不断增长的技术创新、不断增加的肥胖病例以及膝关节关节重建手术有利的报销方案预计将推动这一领域的成长。机器人辅助膝关节关节重建的发展可以改善患者的治疗效果，也是推动细分市场扩张的因素之一。例如，史赛克的 Mako 全膝关节关节重建手术比传统手术带来的不适更少，恢復时间也更短。

整形外科植入市场可依材料分为金属和金属合金、陶瓷、聚合物和混合植入。反向肩关节置换术等关节关节重建手术的数量不断增加，以及寿命和耐腐蚀性等独特特性正在推动这一领域的成长。金属合金比其他材料更便宜且更容易取得。这使其成为患者和其他医疗保健专业人员的合适选择，尤其是在价格敏感的市场，并有望推动该领域的成长。

整形外科植入市场依最终使用者分为医院/手术中心和门诊/创伤照护中心。预计门诊和创伤护理中心在预测期内将显着增长。根据 Definitive Healthcare 的数据，从 2018 年到 2022 年，门诊手术中心进行的膝关节关节重建手术增加了 304%。成本效益和可及性预计将推动该细分市场的成长。此外，微创手术技术带来的更快恢復时间预计将支持该细分市场的成长。

该报告研究了全球整形外科植入市场，包括按产品、材料、最终用户、地区和参与市场的公司概况分類的趋势。

目录

第一章简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章市场概况

  • 介绍
  • 市场动态
  • 价值链分析
  • 供应链分析
  • 生态系分析
  • 监管状况
  • 赎回场景
  • 投资金筹措场景
  • 价格分析
  • 贸易分析
  • 专利分析
  • 波特五力分析
  • 主要相关人员和采购标准
  • 2024-2025年重大会议和活动
  • 案例研究分析
  • 技术分析
  • 影响客户业务的趋势/干扰
  • 未满足的需求
  • 人工智慧/产生人工智慧对整形外科植入市场的影响

第六章整形外科植入市场（按类型）

  • 介绍
  • 膝关节植入
  • 髋植入
  • 肩部植入
  • 手肘植入
  • 脚和脚踝植入
  • 手腕植入
  • 其他的

第七章整形外科植入市场（按材料）

  • 介绍
  • 混合植入
  • 金属和金属合金
  • 聚合物
  • 陶器

第八章整形外科植入市场（按最终用户）

  • 介绍
  • 医院和外科中心
  • 门诊/创伤护理中心

第九章整形外科植入市场（按地区）

  • 介绍
  • 北美洲
    • 北美宏观经济前景
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 亚太宏观经济展望
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 墨西哥
    • 其他的
  • 中东/非洲
    • 扩大高品质治疗的可用性将推动市场
    • 中东/非洲

第10章竞争格局

  • 概述
  • 主要参与企业的策略/优势，2021-2024
  • 2019-2023年收益分析
  • 市场占有率分析
  • 企业评估矩阵：主要参与企业，2023
  • 企业评估矩阵：Start-Ups/小型企业，2023 年
  • 评价及财务指标
  • 品牌/产品比较
  • 竞争场景

第十一章 公司简介

  • 主要参与企业
    • ZIMMER BIOMET HOLDINGS, INC.
    • STRYKER CORPORATION
    • JOHNSON & JOHNSON MEDTECH
    • SMITH+NEPHEW
    • B. BRAUN
    • GLOBUS MEDICAL, INC.
    • ARTHREX, INC.
    • ENOVIS
    • ACUMED LLC
    • ORTHOFIX MEDICAL INC.
    • MICROPORT SCIENTIFIC CORPORATION
    • CONMED CORPORATION
    • MEDACTA INTERNATIONAL
    • PARAGON 28, INC.
    • MERIL LIFE SCIENCES PVT. LTD.
  • 其他公司
    • FH ORTHO SAS
    • SYMBIOS ORTHOPEDIE SA
    • MADISON ORTHO
    • GREEN SURGICALS PVT. LTD.
    • SIORA SURGICALS PRIVATE LIMITED
    • ORTHOPEDIATRICS CORP.
    • RESTOR3D
    • DOUBLE MEDICAL TECHNOLOGY INC.
    • TREACE MEDICAL CONCEPTS, INC.
    • AK MEDICAL HOLDINGS LIMITED

第十二章附录

Product Code: MD 9225

The global orthopedic implants market is expected to reach 26.47 billion by 2029 from USD 20.94 billion in 2024, at a CAGR of 4.8% from 2024 to 2029. Increased access to various type of orthopedic implants and technological advancements such as use of 3D printing with the manufacturing process has increased demand for the orthopedic implants. Further, increased incidence of accidents and sport injuries that may result in fractures and damage to the joints has enhanced the demand for the orthopedic implants.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD)
SegmentsBy Type, material, end user, and region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East Africa.

"The knee implants segment of type segment held the largest share of the market in 2023"

The orthopedic implants market is segmented based on type into knee implants, hip implants, shoulder implants, elbow implants, foot & ankle implants, wrist implants and other implants. The knee implants accounted for a the highest share in 2023. Increase in technological innovations, rise in number of obesity cases and the favorable reimbursement scenario for knee replacement procedures is anticipated to fuel the growth of the segment. Developments in robotic assisted knee replacement procedures that improves patient outcomes is another factor propelling the segment expansion. For example, compared to traditional surgery, the Mako Total Knee Replacement from Stryker Corporation can result in less discomfort and a shorter recovery period.

"The metals and metal alloys segment of material segment held the largest share of the market in 2023"

The orthopedic implants market can be segmented based on material into metals and metal alloys, ceramics, polymers and hybrid implants. Growing number for joint replacement surgeries such as reverse shoulder arthroplasty and unique properties such as longevity and resistance to corrosion drive the segment growth. Metal alloys are less expensive and more readily available than other materials. This makes them an appropriate choice for patients and other healthcare professionals especially in areas of price-sensitive markets, and is expected to fuel the segment growth.

"The ambulatory and trauma care centers segment for the end user segment is projected to register a significant CAGR during the forecast period."

The orthopedic implants market is segmented by end-users into hospitals & surgical centers and ambulatory & trauma care centers. The ambulatory and trauma care centers is projected to register significant growthduring the forecast period. According to Definitive Healthcare there is 304% increase in knee replacement procedures performed in ambulatory surgery centers during the period of 2018-2022. The cost-effectiveness and accessibility anticipated to propel the segment growth. Furthermore, reduced recovery time using minimally invasive surgical techniques is expected to support the growth of this segment.

"The market in the Asia Pacific region is expected to witness the highest growth during the forecast period."

The north america region accounted for major share in 2023. Asia pacific region to grow at the highest CAGR in orthopedic implants market. Healthcare infrastructure and service investments, in the emerging economies, are fostering the demand for orthopedic implants. Furthermore, market leaders have increased their efforts to strengthen their presence in the Asia Pacific market to meet the ever-growing requirement for orthopedic surgeries and joint replacements. According to International Osteoporosis Foundation more than 50% of osteoporotic hip fractures are expected to occur by 2050.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-30%, Tier 2-42%, and Tier 3- 28%
  • By Designation: Director-level-10%, C-level-14%, and Others-76%
  • By Region: North America-40%, Europe-30%, Asia Pacific-22%, Latin America-6%, and Middle East & Africa - 2%

The prominent players in the orthopedic implants market are as Stryker Corporation (US), Zimmer Biomet Holdings,Inc. (US), Johnson & Johnson MedTech (US), Smith+Nephew (UK), B. Braun (Germany), Globus Medical, Inc. (US), Arthrex, Inc.(US), Enovis (US), Acumed LLC (US), Orthofix Medical Inc.(US) , MicroPort Scientiifc Corporation (China), CONMED Corporation (US), Medacta International (Switzerland), Paragon 28, Inc. (US) and, Meril Life Sciences Pvt. Ltd. (India)

The study includes as in-depth competitive analysis of these key players in the authentication and brand protection market, with their company profiles recent developments, and key market stratergies

Research Coverage

This report studies the orthopedic implants market based on type, material, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall orthopedic implants market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

  • Analysis of key drivers (increasing demand for minimally invasive orthopedic surgical procedures and rising number of sports injuries, increasing prevalence of orthopedic diseases and disorders, and increasing research funding and awareness initiatives), restraints (risk and complications associated with orthopedic surgical procedures, high costs of orthopedic surgery), opportunities (growth opportunities in merging markets, advancements in robotic surgery and 3D printing), and challenges (dearth of skilled orthopedic surgeons) influencing the growth of the orthopedic implants market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the orthopedic implants market
  • Market Development: Comprehensive information about lucrative markets-the report analyses the orthopedic implants market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the orthopedic implants market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as Stryker Corporation (US), Zimmer Biomet Holdings, Inc. (US), Johnson & Johnson MedTech (US), Smith+Nephew (UK), B. Braun (Germany).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONS CONSIDERED
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 IMPACT OF AI/GEN AI

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key sources for secondary research
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key primary sources
      • 2.1.2.2 Key industry insights
      • 2.1.2.3 Breakdown of primary interviews
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Company revenue estimation approach
      • 2.2.1.2 Customer-based market estimation
      • 2.2.1.3 Growth forecast approach
      • 2.2.1.4 CAGR projections
  • 2.3 DATA TRIANGULATION
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 RESEARCH ASSUMPTIONS
    • 2.5.1 PARAMETRIC ASSUMPTIONS
    • 2.5.2 GROWTH RATE ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ORTHOPEDIC IMPLANTS MARKET OVERVIEW
  • 4.2 NORTH AMERICA: ORTHOPEDIC IMPLANTS MARKET, BY TYPE
  • 4.3 EUROPE: ORTHOPEDIC IMPLANTS MARKET, BY MATERIAL
  • 4.4 ASIA PACIFIC: ORTHOPEDIC IMPLANTS MARKET, BY END USER (USD MILLION)
  • 4.5 GEOGRAPHIC GROWTH OPPORTUNITIES IN ORTHOPEDIC IMPLANTS MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising prevalence of orthopedic diseases and disorders
      • 5.2.1.2 Increasing demand for minimally invasive surgery
      • 5.2.1.3 Rising number of sports injuries
      • 5.2.1.4 Increasing research funding and awareness initiatives
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Risks and complications associated with orthopedic surgical procedures
      • 5.2.2.2 High cost of orthopedic surgery
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Advancements in robotic surgery and 3D printing
      • 5.2.3.2 Growth opportunities in emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Dearth of skilled orthopedic surgeons
  • 5.3 VALUE CHAIN ANALYSIS
    • 5.3.1 RESEARCH & PRODUCT DEVELOPMENT
    • 5.3.2 RAW MATERIAL PROCUREMENT AND MANUFACTURING
    • 5.3.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
  • 5.4 SUPPLY CHAIN ANALYSIS
    • 5.4.1 MANUFACTURERS
      • 5.4.1.1 Prominent companies
      • 5.4.1.2 Small and medium-sized enterprises
    • 5.4.2 END USERS
  • 5.5 ECOSYSTEM ANALYSIS
  • 5.6 REGULATORY LANDSCAPE
    • 5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.6.2 REGULATORY ANALYSIS
      • 5.6.2.1 North America
        • 5.6.2.1.1 US
        • 5.6.2.1.2 Canada
      • 5.6.2.2 Europe
      • 5.6.2.3 Asia Pacific
        • 5.6.2.3.1 Japan
        • 5.6.2.3.2 China
        • 5.6.2.3.3 India
      • 5.6.2.4 Latin America
        • 5.6.2.4.1 Brazil
    • 5.6.3 REGULATORY APPROVALS
  • 5.7 REIMBURSEMENT SCENARIO
  • 5.8 INVESTMENT AND FUNDING SCENARIO
  • 5.9 PRICING ANALYSIS
    • 5.9.1 AVERAGE SELLING PRICE, BY REGION
    • 5.9.2 AVERAGE SELLING PRICE, BY KEY PLAYER
  • 5.10 TRADE ANALYSIS
    • 5.10.1 IMPORT DATA FOR HS CODE 9021
    • 5.10.2 EXPORT DATA FOR HS CODE 9021
  • 5.11 PATENT ANALYSIS
  • 5.12 PORTER'S FIVE FORCES ANALYSIS
    • 5.12.1 THREAT OF NEW ENTRANTS
    • 5.12.2 THREAT OF SUBSTITUTES
    • 5.12.3 BARGAINING POWER OF SUPPLIERS
    • 5.12.4 BARGAINING POWER OF BUYERS
    • 5.12.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.13.2 KEY BUYING CRITERIA
  • 5.14 KEY CONFERENCES AND EVENTS, 2024-2025
  • 5.15 CASE STUDY ANALYSIS
    • 5.15.1 DIGITAL PLATFORM DESIGNED TO IMPROVE PATIENT CARE PATHWAYS
    • 5.15.2 PARTIAL KNEE ARTHROPLASTY PERFORMED WITH ROSA PARTIAL KNEE SYSTEM
    • 5.15.3 ACCURATE DATA GENERATION WITH SHAPEGRABBER 3D
  • 5.16 TECHNOLOGY ANALYSIS
    • 5.16.1 KEY TECHNOLOGIES
      • 5.16.1.1 3D printing/additive manufacturing
    • 5.16.2 COMPLEMENTARY TECHNOLOGIES
      • 5.16.2.1 Robotic orthopedic surgery
    • 5.16.3 ADJACENT TECHNOLOGIES
      • 5.16.3.1 Diagnostic imaging
  • 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • 5.18 UNMET NEEDS
  • 5.19 IMPACT OF AI/GEN AI ON ORTHOPEDIC IMPLANTS MARKET
    • 5.19.1 KEY USE CASES

6 ORTHOPEDIC IMPLANTS MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 KNEE IMPLANTS
    • 6.2.1 ONGOING INNOVATION IN KNEE IMPLANTS TO SUPPORT GROWTH
  • 6.3 HIP IMPLANTS
    • 6.3.1 RISING NUMBER OF HIP FRACTURES AND INCREASING SUCCESS RATE OF HIP ARTHROPLASTY TO SUPPORT MARKET GROWTH
  • 6.4 SHOULDER IMPLANTS
    • 6.4.1 LAUNCH OF NEW SHOULDER REPLACEMENT IMPLANTS AND RISING POPULARITY OF REVERSE SHOULDER ARTHROPLASTY TO SUPPORT MARKET GROWTH
  • 6.5 ELBOW IMPLANTS
    • 6.5.1 INCREASING FREQUENCY OF ELBOW JOINT FRACTURES AND GROWTH IN ELDERLY POPULATION TO DRIVE MARKET
  • 6.6 FOOT & ANKLE IMPLANTS
    • 6.6.1 RISING NUMBER OF ANKLE REPLACEMENT PROCEDURES TO FUEL MARKET GROWTH
  • 6.7 WRIST IMPLANTS
    • 6.7.1 GROWING NUMBER OF WRIST REPLACEMENT PROCEDURES TO DRIVE MARKET
  • 6.8 OTHER IMPLANTS

7 ORTHOPEDIC IMPLANTS MARKET, BY MATERIAL

  • 7.1 INTRODUCTION
  • 7.2 HYBRID IMPLANTS
    • 7.2.1 IMPROVED BIOCOMPATIBILITY, BETTER MECHANICAL PERFORMANCE, AND REDUCED RISKS OF REVISION SURGERIES TO DRIVE MARKET
  • 7.3 METALS & METAL ALLOYS
    • 7.3.1 STAINLESS STEEL
      • 7.3.1.1 Growing affordability and availability of stainless steel to drive market
    • 7.3.2 TITANIUM ALLOYS
      • 7.3.2.1 Biocompatibility and ability to withstand high stress to propel adoption
    • 7.3.3 OTHER METALS & METAL ALLOYS
  • 7.4 POLYMERS
    • 7.4.1 DESIGN FLEXIBILITY AND TUNABLE PROPERTIES OF POLYMERS TO PROPEL GROWTH
  • 7.5 CERAMICS
    • 7.5.1 LOW FRICTIONAL PROPERTIES AND RESISTANCE AGAINST WEAR TO FUEL MARKET

8 ORTHOPEDIC IMPLANTS MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS & SURGICAL CENTERS
    • 8.2.1 RISING NUMBER OF ORTHOPEDIC SURGERIES TO DRIVE MARKET
  • 8.3 AMBULATORY & TRAUMA CARE CENTERS
    • 8.3.1 COST-EFFECTIVE TREATMENT OFFERED BY AMBULATORY CARE CENTERS TO PROPEL MARKET GROWTH

9 ORTHOPEDIC IMPLANTS MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 9.2.2 US
      • 9.2.2.1 US to dominate North American orthopedic implants market during forecast period
    • 9.2.3 CANADA
      • 9.2.3.1 Rising incidence of degenerative bone diseases to support market growth
  • 9.3 EUROPE
    • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 9.3.2 GERMANY
      • 9.3.2.1 Germany to account for largest market share in Europe
    • 9.3.3 FRANCE
      • 9.3.3.1 Increasing obesity and significant adoption of orthopedic implants to support market growth
    • 9.3.4 UK
      • 9.3.4.1 Increasing awareness of orthopedic conditions to drive adoption of innovative treatments
    • 9.3.5 ITALY
      • 9.3.5.1 Increasing awareness of preventive care for musculoskeletal injuries to drive market
    • 9.3.6 SPAIN
      • 9.3.6.1 Growing preference for minimally invasive surgical procedures to drive market
    • 9.3.7 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 9.4.2 JAPAN
      • 9.4.2.1 Rapidly growing geriatric population to propel market
    • 9.4.3 CHINA
      • 9.4.3.1 Expanding target patient population to drive market
    • 9.4.4 INDIA
      • 9.4.4.1 Increasing number of hospitals adopting robotic-assisted joint replacement surgery to support market growth
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Favorable government initiatives to promote market growth
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Rising R&D and funding to drive market
    • 9.4.7 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 9.5.2 BRAZIL
      • 9.5.2.1 Strong presence of global players to drive market
    • 9.5.3 MEXICO
      • 9.5.3.1 Favorable investment scenario for medical device manufacturers to favor market growth
    • 9.5.4 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 GROWING AVAILABILITY OF HIGH-QUALITY TREATMENTS TO DRIVE MARKET
    • 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021-2024
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ORTHOPEDIC IMPLANTS MARKET
  • 10.3 REVENUE ANALYSIS, 2019-2023
  • 10.4 MARKET SHARE ANALYSIS
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 10.5.5.1 Company footprint
      • 10.5.5.2 Region footprint
      • 10.5.5.3 Type footprint
      • 10.5.5.4 Material footprint
      • 10.5.5.5 End-user footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 RESPONSIVE COMPANIES
    • 10.6.3 DYNAMIC COMPANIES
    • 10.6.4 STARTING BLOCKS
    • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 10.7 VALUATION & FINANCIAL METRICS
    • 10.7.1 FINANCIAL METRICS
    • 10.7.2 COMPANY VALUATION
  • 10.8 BRAND/PRODUCT COMPARISON
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 PRODUCT LAUNCHES & APPROVALS
    • 10.9.2 DEALS
    • 10.9.3 EXPANSIONS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 ZIMMER BIOMET HOLDINGS, INC.
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Product approvals
        • 11.1.1.3.2 Deals
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Key strengths
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses and competitive threats
    • 11.1.2 STRYKER CORPORATION
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products offered
      • 11.1.2.3 Recent developments
        • 11.1.2.3.1 Deals
        • 11.1.2.3.2 Expansions
      • 11.1.2.4 MnM view
        • 11.1.2.4.1 Right to win
        • 11.1.2.4.2 Strategic choices
        • 11.1.2.4.3 Weaknesses and competitive threats
    • 11.1.3 JOHNSON & JOHNSON MEDTECH
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Product launches & approvals
        • 11.1.3.3.2 Deals
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Right to win
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses and competitive threats
    • 11.1.4 SMITH+NEPHEW
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products offered
      • 11.1.4.3 Recent developments
        • 11.1.4.3.1 Product launches & approvals
        • 11.1.4.3.2 Deals
        • 11.1.4.3.3 Expansions
    • 11.1.5 B. BRAUN
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products offered
    • 11.1.6 GLOBUS MEDICAL, INC.
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products offered
      • 11.1.6.3 Recent developments
        • 11.1.6.3.1 Product launches & approvals
        • 11.1.6.3.2 Deals
    • 11.1.7 ARTHREX, INC.
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products offered
    • 11.1.8 ENOVIS
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products offered
      • 11.1.8.3 Recent developments
        • 11.1.8.3.1 Product launches
        • 11.1.8.3.2 Deals
        • 11.1.8.3.3 Expansions
    • 11.1.9 ACUMED LLC
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products offered
      • 11.1.9.3 Recent developments
        • 11.1.9.3.1 Product launches
        • 11.1.9.3.2 Deals
        • 11.1.9.3.3 Expansions
    • 11.1.10 ORTHOFIX MEDICAL INC.
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products offered
      • 11.1.10.3 Recent developments
        • 11.1.10.3.1 Product launches & approvals
        • 11.1.10.3.2 Deals
    • 11.1.11 MICROPORT SCIENTIFIC CORPORATION
      • 11.1.11.1 Business overview
      • 11.1.11.2 Products offered
      • 11.1.11.3 Recent developments
        • 11.1.11.3.1 Product launches
        • 11.1.11.3.2 Deals
    • 11.1.12 CONMED CORPORATION
      • 11.1.12.1 Business overview
      • 11.1.12.2 Products offered
      • 11.1.12.3 Recent developments
        • 11.1.12.3.1 Deals
    • 11.1.13 MEDACTA INTERNATIONAL
      • 11.1.13.1 Business overview
      • 11.1.13.2 Products offered
      • 11.1.13.3 Recent developments
        • 11.1.13.3.1 Product approvals
        • 11.1.13.3.2 Deals
        • 11.1.13.3.3 Expansions
    • 11.1.14 PARAGON 28, INC.
      • 11.1.14.1 Business overview
      • 11.1.14.2 Products offered
      • 11.1.14.3 Recent developments
        • 11.1.14.3.1 Product launches & approvals
        • 11.1.14.3.2 Deals
    • 11.1.15 MERIL LIFE SCIENCES PVT. LTD.
      • 11.1.15.1 Business overview
      • 11.1.15.2 Products offered
      • 11.1.15.3 Recent developments
        • 11.1.15.3.1 Expansions
  • 11.2 OTHER PLAYERS
    • 11.2.1 FH ORTHO SAS
    • 11.2.2 SYMBIOS ORTHOPEDIE S.A.
    • 11.2.3 MADISON ORTHO
    • 11.2.4 GREEN SURGICALS PVT. LTD.
    • 11.2.5 SIORA SURGICALS PRIVATE LIMITED
    • 11.2.6 ORTHOPEDIATRICS CORP.
    • 11.2.7 RESTOR3D
    • 11.2.8 DOUBLE MEDICAL TECHNOLOGY INC.
    • 11.2.9 TREACE MEDICAL CONCEPTS, INC.
    • 11.2.10 AK MEDICAL HOLDINGS LIMITED

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 ORTHOPEDIC IMPLANTS MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 GRANTS AND FUNDING OPPORTUNITIES IN ORTHOPEDIC IMPLANTS MARKET
  • TABLE 3 ORTHOPEDIC IMPLANTS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 4 NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 5 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 MIDDLE EAST & AFRICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 10 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 11 US: CLASSIFICATION OF ORTHOPEDIC IMPLANTS
  • TABLE 12 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 13 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)
  • TABLE 14 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 15 REGULATORY APPROVALS FOR ORTHOPEDIC IMPLANTS, BY COUNTRY
  • TABLE 16 MEDICAL REIMBURSEMENT CODES FOR ORTHOPEDIC IMPLANTATION SERVICES, 2023
  • TABLE 17 AVERAGE SELLING PRICE TREND OF ORTHOPEDIC IMPLANTS, BY REGION, 2021-2023 (USD)
  • TABLE 18 AVERAGE SELLING PRICE OF ORTHOPEDIC IMPLANTS, BY KEY PLAYER, 2023 (USD)
  • TABLE 19 IMPORT DATA FOR ORTHOPEDIC IMPLANTS (HS CODE 9021), BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 20 EXPORT DATA FOR ORTHOPEDIC IMPLANTS (HS CODE 9021), BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 21 INNOVATIONS AND PATENT REGISTRATIONS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 22 ORTHOPEDIC IMPLANTS MARKET: PORTER'S FIVE FORCES
  • TABLE 23 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF ORTHOPEDIC IMPLANTS
  • TABLE 24 INFLUENCE OF END USERS ON PURCHASE OF ORTHOPEDIC IMPLANTS, BY END USER
  • TABLE 25 ORTHOPEDIC IMPLANTS MARKET: LIST OF CONFERENCES AND EVENTS
  • TABLE 26 ORTHOPEDIC IMPLANTS MARKET: CURRENT UNMET NEEDS
  • TABLE 27 ORTHOPEDIC IMPLANTS MARKET: INTENSITY OF CURRENT UNMET NEEDS
  • TABLE 28 ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 29 KNEE IMPLANTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 30 HIP IMPLANTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 31 SHOULDER IMPLANTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 32 ELBOW IMPLANTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 33 FOOT & ANKLE IMPLANTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 34 WRIST IMPLANTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 35 OTHER ORTHOPEDIC IMPLANTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 36 ORTHOPEDIC IMPLANTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 37 HYBRID IMPLANTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 38 METAL & METAL ALLOY IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 39 METAL & METAL ALLOY IMPLANTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 40 STAINLESS STEEL IMPLANTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 41 TITANIUM ALLOY IMPLANTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 42 OTHER METAL & METAL ALLOY IMPLANTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 43 POLYMER IMPLANTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 44 CERAMIC IMPLANTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 45 ORTHOPEDIC IMPLANTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 46 ORTHOPEDIC IMPLANTS MARKET FOR HOSPITALS & SURGICAL CENTERS BY REGION, 2022-2029 (USD MILLION)
  • TABLE 47 ORTHOPEDIC IMPLANTS MARKET FOR AMBULATORY & TRAUMA CARE CENTERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 48 ORTHOPEDIC IMPLANTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 49 NORTH AMERICA: ORTHOPEDIC IMPLANTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 50 NORTH AMERICA: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 51 NORTH AMERICA: ORTHOPEDIC IMPLANTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 52 NORTH AMERICA: METAL & METAL ALLOY IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 53 NORTH AMERICA: ORTHOPEDIC IMPLANTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 54 NORTH AMERICA: KEY MACROINDICATORS
  • TABLE 55 US: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 56 CANADA: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 57 EUROPE: KEY MACROINDICATORS
  • TABLE 58 EUROPE: ORTHOPEDIC IMPLANTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 59 EUROPE: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 60 EUROPE: ORTHOPEDIC IMPLANTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 61 EUROPE: METAL & METAL ALLOY IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 62 EUROPE: ORTHOPEDIC IMPLANTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 63 GERMANY: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 64 FRANCE: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 65 UK: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 66 ITALY: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 67 SPAIN: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 68 REST OF EUROPE: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 69 ASIA PACIFIC: KEY MACROINDICATORS
  • TABLE 70 ASIA PACIFIC: ORTHOPEDIC IMPLANTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 71 ASIA PACIFIC: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 72 ASIA PACIFIC: ORTHOPEDIC IMPLANTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 73 ASIA PACIFIC: METAL & METAL ALLOY IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 74 ASIA PACIFIC: ORTHOPEDIC IMPLANTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 75 JAPAN: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 76 CHINA: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 77 INDIA: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 78 AUSTRALIA: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 79 SOUTH KOREA: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 80 REST OF ASIA PACIFIC: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 81 LATIN AMERICA: KEY MACROINDICATORS
  • TABLE 82 LATIN AMERICA: ORTHOPEDIC IMPLANTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 83 LATIN AMERICA: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 84 LATIN AMERICA: ORTHOPEDIC IMPLANTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 85 LATIN AMERICA: METAL & METAL ALLOY IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 86 LATIN AMERICA: ORTHOPEDIC IMPLANTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 87 BRAZIL: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 88 MEXICO: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 89 REST OF LATIN AMERICA: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 90 MIDDLE EAST & AFRICA: KEY MACROINDICATORS
  • TABLE 91 MIDDLE EAST & AFRICA: ORTHOPEDIC IMPLANTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 92 MIDDLE EAST & AFRICA: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 93 MIDDLE EAST & AFRICA: ORTHOPEDIC IMPLANTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 94 MIDDLE EAST & AFRICA: METAL & METAL ALLOY IMPLANTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 95 MIDDLE EAST & AFRICA: ORTHOPEDIC IMPLANTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 96 ORTHOPEDIC IMPLANTS MARKET: OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES, 2021-2024
  • TABLE 97 ORTHOPEDIC IMPLANTS MARKET: DEGREE OF COMPETITION
  • TABLE 98 ORTHOPEDIC IMPLANTS MARKET: REGION FOOTPRINT
  • TABLE 99 ORTHOPEDIC IMPLANTS MARKET: TYPE FOOTPRINT
  • TABLE 100 ORTHOPEDIC IMPLANTS MARKET: MATERIAL FOOTPRINT
  • TABLE 101 ORTHOPEDIC IMPLANTS MARKET: END-USER FOOTPRINT
  • TABLE 102 ORTHOPEDIC IMPLANTS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 103 ORTHOPEDIC IMPLANTS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 104 ORTHOPEDIC IMPLANTS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021- OCTOBER 2024
  • TABLE 105 ORTHOPEDIC IMPLANTS MARKET: DEALS, JANUARY 2021- OCTOBER 2024
  • TABLE 106 ORTHOPEDIC IMPLANTS MARKET: EXPANSIONS, JANUARY 2021-OCTOBER 2024
  • TABLE 107 ZIMMER BIOMET HOLDINGS: COMPANY OVERVIEW
  • TABLE 108 ZIMMER BIOMET HOLDINGS: PRODUCTS OFFERED
  • TABLE 109 ZIMMER BIOMET HOLDINGS: PRODUCT APPROVALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 110 ZIMMER BIOMET HOLDINGS: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 111 STRYKER CORPORATION: COMPANY OVERVIEW
  • TABLE 112 STRYKER CORPORATION: PRODUCTS OFFERED
  • TABLE 113 STRYKER CORPORATION: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 114 STRYKER CORPORATION: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 115 JOHNSON & JOHNSON MEDTECH: COMPANY OVERVIEW
  • TABLE 116 JOHNSON & JOHNSON MEDTECH: PRODUCTS OFFERED
  • TABLE 117 JOHNSON & JOHNSON MEDTECH: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 118 JOHNSON & JOHNSON MEDTECH: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 119 SMITH+NEPHEW: COMPANY OVERVIEW
  • TABLE 120 SMITH+NEPHEW: PRODUCTS OFFERED
  • TABLE 121 SMITH+NEPHEW: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 122 SMITH+NEPHEW: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 123 SMITH+NEPHEW: EXPANSIONS, JANUARY 2021- AUGUST 2024
  • TABLE 124 B. BRAUN: COMPANY OVERVIEW
  • TABLE 125 B. BRAUN: PRODUCTS OFFERED
  • TABLE 126 GLOBUS MEDICAL: COMPANY OVERVIEW
  • TABLE 127 GLOBUS MEDICAL: PRODUCTS OFFERED
  • TABLE 128 GLOBUS MEDICAL: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 129 GLOBUS MEDICAL: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 130 ARTHREX: COMPANY OVERVIEW
  • TABLE 131 ARTHREX: PRODUCTS OFFERED
  • TABLE 132 ENOVIS: COMPANY OVERVIEW
  • TABLE 133 ENOVIS: PRODUCTS OFFERED
  • TABLE 134 ENOVIS: PRODUCT LAUNCHES, JANUARY 2021-SEPTEMBER 2024
  • TABLE 135 ENOVIS: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 136 ENOVIS: EXPANSIONS, JANUARY 2021- AUGUST 2024
  • TABLE 137 ACUMED: COMPANY OVERVIEW
  • TABLE 138 ACUMED: PRODUCTS OFFERED
  • TABLE 139 ACUMED: PRODUCT LAUNCHES, JANUARY 2021-SEPTEMBER 2024
  • TABLE 140 ACUMED: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 141 ACUMED: EXPANSIONS, JANUARY 2021- AUGUST 2024
  • TABLE 142 ORTHOFIX MEDICAL: COMPANY OVERVIEW
  • TABLE 143 ORTHOFIX MEDICAL: PRODUCTS OFFERED
  • TABLE 144 ORTHOFIX MEDICAL: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 145 ORTHOFIX MEDICAL: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 146 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 147 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 148 MICROPORT SCIENTIFIC CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-SEPTEMBER 2024
  • TABLE 149 MICROPORT SCIENTIFIC CORPORATION: DEALS, JANUARY 2021- SEPTEMBER 2024
  • TABLE 150 CONMED CORPORATION: COMPANY OVERVIEW
  • TABLE 151 CONMED CORPORATION: PRODUCTS OFFERED
  • TABLE 152 CONMED CORPORATION: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 153 MEDACTA INTERNATIONAL: COMPANY OVERVIEW
  • TABLE 154 MEDACTA INTERNATIONAL: PRODUCTS OFFERED
  • TABLE 155 MEDACTA INTERNATIONAL: PRODUCT APPROVALS, JANUARY 2021- SEPTEMBER 2024
  • TABLE 156 MEDACTA INTERNATIONAL: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 157 MEDACTA INTERNATIONAL: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 158 PARAGON 28: COMPANY OVERVIEW
  • TABLE 159 PARAGON 28: PRODUCTS OFFERED
  • TABLE 160 PARAGON 28: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021- SEPTEMBER 2024
  • TABLE 161 PARAGON 28: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 162 MERIL LIFE SCIENCES: COMPANY OVERVIEW
  • TABLE 163 MERIL LIFE SCIENCES: PRODUCTS OFFERED
  • TABLE 164 MERIL LIFE SCIENCES: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024

List of Figures

  • FIGURE 1 ORTHOPEDIC IMPLANTS MARKET SEGMENTATION
  • FIGURE 2 ORTHOPEDIC IMPLANTS MARKET: RESEARCH DESIGN
  • FIGURE 3 ORTHOPEDIC IMPLANTS MARKET: KEY PRIMARY SOURCES (DEMAND- AND SUPPLY-SIDE PARTICIPANTS)
  • FIGURE 4 ORTHOPEDIC IMPLANTS: KEY INSIGHTS FROM PRIMARY INTERVIEWS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 7 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 8 ORTHOPEDIC IMPLANTS MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION
  • FIGURE 9 ORTHOPEDIC IMPLANTS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 10 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
  • FIGURE 11 DATA TRIANGULATION METHODOLOGY
  • FIGURE 12 ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 ORTHOPEDIC IMPLANTS MARKET, BY MATERIAL, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 ORTHOPEDIC IMPLANTS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 GEOGRAPHIC SNAPSHOT OF ORTHOPEDIC IMPLANTS MARKET
  • FIGURE 16 RISING PREVALENCE OF ORTHOPEDIC DISEASES AND DISORDERS TO DRIVE MARKET GROWTH
  • FIGURE 17 HIP IMPLANTS SEGMENT TO REGISTER SIGNIFICANT GROWTH IN NORTH AMERICAN MARKET
  • FIGURE 18 HYBRID IMPLANTS TO HOLD LARGEST SHARE IN EUROPE
  • FIGURE 19 HOSPITALS & SURGICAL CENTERS SEGMENT TO REGISTER SIGNIFICANT GROWTH IN APAC END-USER MARKET
  • FIGURE 20 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 21 ORTHOPEDIC IMPLANTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22 ORTHOPEDIC IMPLANTS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 23 ORTHOPEDIC IMPLANTS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 24 ORTHOPEDIC IMPLANTS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 25 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES
  • FIGURE 26 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
  • FIGURE 27 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES
  • FIGURE 28 INVESTMENT AND FUNDING SCENARIO IN ORTHOPEDIC IMPLANTS MARKET, 2019-2023 (USD MILLION)
  • FIGURE 29 NUMBER OF INVESTOR DEALS IN ORTHOPEDIC IMPLANTS MARKET, BY KEY PLAYER, 2019-2023 (UNIT)
  • FIGURE 30 VALUE OF INVESTOR DEALS IN ORTHOPEDIC IMPLANTS MARKET, BY KEY PLAYER, 2018-2022 (USD MILLION)
  • FIGURE 31 AVERAGE SELLING PRICE OF ORTHOPEDIC IMPLANTS, BY PRODUCT, 2023 (USD)
  • FIGURE 32 AVERAGE SELLING PRICE OF ORTHOPEDIC IMPLANTS, BY REGION, 2023 (USD)
  • FIGURE 33 ORTHOPEDIC IMPLANTS MARKET: PATENT ANALYSIS, 2013-2023
  • FIGURE 34 ORTHOPEDIC IMPLANTS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ORTHOPEDIC IMPLANTS
  • FIGURE 36 KEY BUYING CRITERIA, BY END USER
  • FIGURE 37 NEW REVENUE POCKETS FOR PLAYERS IN ORTHOPEDIC IMPLANTS MARKET
  • FIGURE 38 MARKET POTENTIAL OF AI/GENERATIVE AI IN ORTHOPEDIC IMPLANTS MARKET
  • FIGURE 39 NORTH AMERICA: ORTHOPEDIC IMPLANTS MARKET SNAPSHOT
  • FIGURE 40 ASIA PACIFIC: ORTHOPEDIC IMPLANTS MARKET SNAPSHOT
  • FIGURE 41 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN ORTHOPEDIC IMPLANTS MARKET (2019-2023)
  • FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)
  • FIGURE 43 ORTHOPEDIC IMPLANTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 44 ORTHOPEDIC IMPLANTS MARKET: COMPANY FOOTPRINT
  • FIGURE 45 ORTHOPEDIC IMPLANTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 46 EV/EBITDA OF KEY VENDORS
  • FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 48 ORTHOPEDIC IMPLANTS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 49 ZIMMER BIOMET HOLDINGS: COMPANY SNAPSHOT (2023)
  • FIGURE 50 STRYKER CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 51 JOHNSON & JOHNSON MEDTECH: COMPANY SNAPSHOT (2023)
  • FIGURE 52 SMITH+NEPHEW: COMPANY SNAPSHOT (2023)
  • FIGURE 53 B. BRAUN: COMPANY SNAPSHOT (2023)
  • FIGURE 54 GLOBUS MEDICAL: COMPANY SNAPSHOT (2023)
  • FIGURE 55 ENOVIS: COMPANY SNAPSHOT (2023)
  • FIGURE 56 ORTHOFIX MEDICAL: COMPANY SNAPSHOT (2023)
  • FIGURE 57 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 58 CONMED CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 59 MEDACTA INTERNATIONAL: COMPANY SNAPSHOT (2023)
  • FIGURE 60 PARAGON 28: COMPANY SNAPSHOT (2023)